N-Acetyl Semax Amidate is a modified, stabilized analog of Semax studied in nootropic and neurotrophic research contexts.
N-Acetyl Semax Amidate is a chemically stabilized analog of Semax, a peptide derived from a fragment of ACTH. The N-acetylation and amidation are intended to improve resistance to enzymatic degradation. It is studied in research contexts related to nootropic activity, neurotrophic signalling, and neuroprotection.
Semax-family research generally examines effects on brain-derived neurotrophic factor pathways, neuroprotective signalling, and cognitive-performance models. The modified analog is investigated for potentially prolonged and enhanced activity, with data drawn primarily from preclinical studies.
Studied for potential effects on cognitive-performance pathways in experimental research models.
Investigated for possible influence on BDNF-related signalling in preclinical research settings.
Examined for potential neuroprotective signalling effects within experimental neural models.
Researched for improved degradation resistance from N-acetylation and amidation modifications.
Bring the vial (30 mg) and bacteriostatic water to room temperature.
Add bacteriostatic water slowly along the glass wall — the volume you add sets the concentration.
Swirl gently (do not shake) until fully clear, then refrigerate at 2–8 °C.
Studied together as complementary stabilized peptide analogs in nootropic research models.
Explored in combination for potential nootropic and neurotrophic signalling effects.
Links open a PubMed search for the topic. They point to independent literature and are provided for orientation in a research context only.
It is a stabilized analog of Semax, an ACTH-fragment peptide, modified by N-acetylation and amidation to improve durability. It is studied in nootropic and neurotrophic research.
The modifications are designed to enhance stability and resistance to degradation, potentially prolonging activity, which is a key focus of comparative peptide research.
It is studied for potential effects on cognitive-performance pathways, BDNF-related neurotrophic signalling, and neuroprotection in preclinical neural and behavioral research models.
See the product, or build a stack around it.
View product →Open Stack-Builder →
You must be at least 21 years old to enter this website.
By clicking "Confirm & Enter", you confirm that you are 21 years of age or older and understand that all products sold on this website are intended for research purposes only.
